Photocure - Asset Resilience Ratio

Latest as of December 2025: 33.79%

Photocure (PHO) has an Asset Resilience Ratio of 33.79% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Photocure's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Nkr238.89 Million

≈ $25.14 Million USD Cash + Short-term Investments

Total Assets

Nkr707.06 Million

≈ $74.40 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Photocure's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Photocure.

Liquid Assets Composition Over Time

This chart breaks down Photocure's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore PHO strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Nkr238.89 Million	33.79%
Short-term Investments	Nkr0.00	0%
Total Liquid Assets	Nkr238.89 Million	33.79%

Asset Resilience Insights

Very High Liquidity: Photocure maintains exceptional liquid asset reserves at 33.79% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Photocure Industry Peers by Asset Resilience Ratio

Compare Photocure's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Beijing Winsunny Pharmaceutical CO.LTD SHG:601089	Drug Manufacturers - Specialty & Generic	10.89%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%
Chongqing Taiji Industry Group Co Ltd SHG:600129	Drug Manufacturers - Specialty & Generic	0.47%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%

Annual Asset Resilience Ratio for Photocure (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Photocure.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	33.79%	Nkr238.89 Million ≈ $25.14 Million	Nkr707.06 Million ≈ $74.40 Million	-5.29pp
2024-12-31	39.08%	Nkr288.83 Million ≈ $30.39 Million	Nkr739.09 Million ≈ $77.77 Million	+3.08pp
2023-12-31	36.00%	Nkr256.34 Million ≈ $26.97 Million	Nkr711.97 Million ≈ $74.92 Million	-0.80pp
2022-12-31	36.81%	Nkr264.65 Million ≈ $27.85 Million	Nkr719.03 Million ≈ $75.66 Million	-3.60pp
2021-12-31	40.40%	Nkr319.04 Million ≈ $33.57 Million	Nkr789.65 Million ≈ $83.09 Million	-2.06pp
2020-12-31	42.46%	Nkr329.53 Million ≈ $34.68 Million	Nkr776.05 Million ≈ $81.66 Million	-4.63pp
2019-12-31	47.10%	Nkr121.20 Million ≈ $12.75 Million	Nkr257.35 Million ≈ $27.08 Million	-31.46pp
2018-12-31	78.56%	Nkr181.62 Million ≈ $19.11 Million	Nkr231.20 Million ≈ $24.33 Million	-7.45pp
2017-12-31	86.00%	Nkr226.28 Million ≈ $23.81 Million	Nkr263.10 Million ≈ $27.69 Million	+84.36pp
2015-12-31	1.64%	Nkr4.08 Million ≈ $428.81K	Nkr248.06 Million ≈ $26.10 Million	+0.17pp
2014-12-31	1.48%	Nkr4.00 Million ≈ $420.39K	Nkr270.58 Million ≈ $28.47 Million	+1.44pp
2013-12-31	0.04%	Nkr117.00K ≈ $12.31K	Nkr301.73 Million ≈ $31.75 Million	-0.94pp
2012-12-31	0.98%	Nkr4.24 Million ≈ $446.49K	Nkr432.98 Million ≈ $45.56 Million	+0.18pp
2011-12-31	0.80%	Nkr4.09 Million ≈ $430.81K	Nkr509.18 Million ≈ $53.58 Million	-66.19pp
2010-12-31	66.99%	Nkr344.24 Million ≈ $36.22 Million	Nkr513.84 Million ≈ $54.07 Million	-16.26pp
2009-12-31	83.25%	Nkr380.33 Million ≈ $40.02 Million	Nkr456.86 Million ≈ $48.08 Million	+82.01pp
2008-12-31	1.24%	Nkr2.94 Million ≈ $309.69K	Nkr237.85 Million ≈ $25.03 Million	+0.30pp
2007-12-31	0.94%	Nkr2.82 Million ≈ $296.96K	Nkr301.39 Million ≈ $31.72 Million	-55.04pp
2005-12-31	55.98%	Nkr59.17 Million ≈ $6.23 Million	Nkr105.70 Million ≈ $11.12 Million	-11.23pp
2004-12-31	67.20%	Nkr116.74 Million ≈ $12.28 Million	Nkr173.71 Million ≈ $18.28 Million	-6.68pp
2003-12-31	73.88%	Nkr172.44 Million ≈ $18.15 Million	Nkr233.40 Million ≈ $24.56 Million	+1.12pp
2002-12-31	72.76%	Nkr217.55 Million ≈ $22.89 Million	Nkr299.01 Million ≈ $31.46 Million	-16.58pp
2001-12-31	89.34%	Nkr285.49 Million ≈ $30.04 Million	Nkr319.57 Million ≈ $33.63 Million	-1.80pp
2000-12-31	91.13%	Nkr368.95 Million ≈ $38.82 Million	Nkr404.85 Million ≈ $42.60 Million	--

pp = percentage points

About Photocure

OL:PHO Norway Drug Manufacturers - Specialty & Generic

Market Cap

$141.05 Million

Nkr1.34 Billion NOK

Market Cap Rank

#17945 Global

#156 in Norway

Share Price

Nkr49.80

Change (1 day)

-1.97%

52-Week Range

Nkr48.10 - Nkr79.00

All Time High

Nkr150.90